BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30822416)

  • 1. Plasma free metanephrines for diagnosis of neuroblastoma patients.
    Barco S; Verly I; Corrias MV; Sorrentino S; Conte M; Tripodi G; Tytgat G; van Kuilenburg A; van der Ham M; de Sain-van der Velden M; Garaventa A; Cangemi G
    Clin Biochem; 2019 Apr; 66():57-62. PubMed ID: 30822416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites.
    van Duinen N; Corssmit EP; de Jong WH; Brookman D; Kema IP; Romijn JA
    Eur J Endocrinol; 2013 Sep; 169(3):377-82. PubMed ID: 23832865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
    Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Bešťák J; Widimský J
    Physiol Res; 2015; 64(Suppl 2):S313-22. PubMed ID: 26680494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric reference intervals for plasma free and total metanephrines established with a parametric approach: relevance to the diagnosis of neuroblastoma.
    Franscini LC; Vazquez-Montes M; Buclin T; Perera R; Dunand M; Grouzmann E; Beck-Popovic M
    Pediatr Blood Cancer; 2015 Apr; 62(4):587-93. PubMed ID: 25597761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high sensitivity LC-MS/MS method for measurement of 3-methoxytyramine in plasma and associations between 3-methoxytyramine, metanephrines, and dopamine.
    Smy L; Kushnir MM; Frank EL
    J Mass Spectrom Adv Clin Lab; 2021 Aug; 21():19-26. PubMed ID: 34820673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine.
    Eisenhofer G; Peitzsch M; Kaden D; Langton K; Mangelis A; Pamporaki C; Masjkur J; Geroula A; Kurlbaum M; Deutschbein T; Beuschlein F; Prejbisz A; Bornstein SR; Lenders JWM
    Clin Chim Acta; 2019 Mar; 490():46-54. PubMed ID: 30571948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors.
    de Jong WH; Eisenhofer G; Post WJ; Muskiet FA; de Vries EG; Kema IP
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2841-9. PubMed ID: 19567530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
    Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple and rapid analytical method based on solid-phase extraction and liquid chromatography-tandem mass spectrometry for the simultaneous determination of free catecholamines and metanephrines in urine and its application to routine clinical analysis.
    Woo HI; Yang JS; Oh HJ; Cho YY; Kim JH; Park HD; Lee SY
    Clin Biochem; 2016 May; 49(7-8):573-9. PubMed ID: 26779993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of specific high-performance liquid-chromatographic determinations of urinary metanephrine and normetanephrine by comparison with isotope dilution mass spectrometry.
    Willemsen JJ; Ross HA; Wolthers BG; Sweep CG; Kema IP
    Ann Clin Biochem; 2001 Nov; 38(Pt 6):722-30. PubMed ID: 11732660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-specific pediatric reference intervals for plasma free normetanephrine, metanephrine, 3-methoxytyramine and 3-O-methyldopa: Particular importance for early infancy.
    Peitzsch M; Mangelis A; Eisenhofer G; Huebner A
    Clin Chim Acta; 2019 Jul; 494():100-105. PubMed ID: 30904545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylated catecholamine metabolites for diagnosis of neuroblastoma.
    Candito M; Thyss A; Albertini M; Deville A; Politano S; Mariani R; Chambon P
    Med Pediatr Oncol; 1992; 20(3):215-20. PubMed ID: 1574031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of an assay for quantification of free normetanephrine, metanephrine and methoxytyramine in plasma by high performance liquid chromatography with coulometric detection: Comparison of peak-area vs. peak-height measurements.
    Nieć D; Kunicki PK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():63-70. PubMed ID: 26310898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of an improved liquid chromatography tandem mass spectrometry method for rapid and simultaneous analysis of plasma catecholamine and their metabolites.
    Yu S; Yin Y; Li Q; Yu J; Liu W; Wang D; Cheng Q; Xie S; Cheng X; Qiu L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Oct; 1129():121805. PubMed ID: 31670057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma.
    Lagerstedt SA; O'Kane DJ; Singh RJ
    Clin Chem; 2004 Mar; 50(3):603-11. PubMed ID: 14726465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma.
    Peitzsch M; Prejbisz A; Kroiß M; Beuschlein F; Arlt W; Januszewicz A; Siegert G; Eisenhofer G
    Ann Clin Biochem; 2013 Mar; 50(Pt 2):147-55. PubMed ID: 23512172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Random 'spot' urinary metanephrines compared with 24-h-urinary and plasma results in phaeochromocytomas and paragangliomas.
    Sbardella E; Maunsell Z; May CJH; Tadman M; James T; Jafar-Mohammadi B; Isidori AM; Grossman AB; Shine B
    Eur J Endocrinol; 2020 Aug; 183(2):129-139. PubMed ID: 32413848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of liquid chromatography-tandem mass spectrometry method for analysis of urinary conjugated metanephrine and normetanephrine for screening of pheochromocytoma.
    Taylor RL; Singh RJ
    Clin Chem; 2002 Mar; 48(3):533-9. PubMed ID: 11861444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of plasma free metanephrines measured by liquid chromatography-tandem mass spectrometry in the diagnosis of pheochromocytoma.
    Peaston RT; Graham KS; Chambers E; van der Molen JC; Ball S
    Clin Chim Acta; 2010 Apr; 411(7-8):546-52. PubMed ID: 20083099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High specificity of spot urinary free metanephrines in diagnosis and prognosis of pheochromocytomas and paragangliomas by HPLC with electrochemical detection.
    Zuo M; Zhen Q; Zhang X; Zou W; Yang X; Tian G; Shi Z; Li Q; Ding M
    Clin Chim Acta; 2018 Mar; 478():82-89. PubMed ID: 29273559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.